A case of hydralazine-induced bullous pemphigoid
AboutOpen · 13.03.2026 · 13 (1) · 14-15
DOI: 10.33393/ao.2026.3710 ↗Kurz gefasst
Fachartikel in der Zeitschrift AboutOpen, online erschienen am 13.03.2026. Verfasst von Paul Zammit. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Hydralazine-induced bullous pemphigoid (BP) is a rare adverse drug reaction where the medicationmay act to trigger an autoimmune response against proteins in the dermal-epidermal junction (DEJ). This casehighlights the necessity of considering hydralazine as a potential cause of BP.Case Description: An 89-year-old Caucasian lady developed generalized, itchy, bullous rashes approximately twoweeks after her doctor initiated hydralazine for high blood pressure. BP secondary to hydralazine was suspected.A skin biopsy with direct immunofluorescence (DIF) confirmed the diagnosis, showing linear deposition of IgMand C3 along the basement membrane zone.
Conclusion
The cornerstone of management was the immediate discontinuation of hydralazine, and the patientwas started on oral prednisolone. Her rashes started disappearing within days and resolved within one month,demonstrating the good prognosis often seen with prompt drug withdrawal.
Zitieren
APA
Zammit, P. (2026). A case of hydralazine-induced bullous pemphigoid. AboutOpen, 13(1), 14-15. https://doi.org/10.33393/ao.2026.3710
Vancouver
Zammit P. A case of hydralazine-induced bullous pemphigoid. AboutOpen. 2026;13(1):14-15. doi:10.33393/ao.2026.3710
BibTeX
@article{Zammit2026,
author = {Zammit, Paul},
title = {A case of hydralazine-induced bullous pemphigoid},
journal = {AboutOpen},
year = {2026},
volume = {13},
number = {1},
pages = {14--15},
doi = {10.33393/ao.2026.3710}
}
EUVIMED